×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALMS – alumis inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALMS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/20
09:24 am
alms
Alumis (ALMS) had its price target raised by Morgan Stanley from $33.00 to $38.00. They now have an "overweight" rating on the stock.
Medium
Report
Alumis (ALMS) had its price target raised by Morgan Stanley from $33.00 to $38.00. They now have an "overweight" rating on the stock.
3/20
08:26 am
alms
Alumis (ALMS) had its price target raised by Chardan Capital from $37.00 to $38.00. They now have a "buy" rating on the stock.
Low
Report
Alumis (ALMS) had its price target raised by Chardan Capital from $37.00 to $38.00. They now have a "buy" rating on the stock.
3/19
04:55 pm
alms
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements [Yahoo! Finance]
Low
Report
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements [Yahoo! Finance]
3/19
04:05 pm
alms
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements
Low
Report
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements
3/18
08:45 am
alms
Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting [Yahoo! Finance]
Low
Report
Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting [Yahoo! Finance]
3/18
08:00 am
alms
Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting
Low
Report
Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting
3/10
05:04 pm
alms
Alumis (ALMS) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
Medium
Report
Alumis (ALMS) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
3/2
08:05 am
alms
Alumis to Present at the Leerink Partners Global Healthcare Conference
Low
Report
Alumis to Present at the Leerink Partners Global Healthcare Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
04:23 pm
alms
Form 10-K ALUMIS INC. For: Dec 31
Low
Report
Form 10-K ALUMIS INC. For: Dec 31
3/19
04:13 pm
alms
Form 8-K ALUMIS INC. For: Mar 19
Low
Report
Form 8-K ALUMIS INC. For: Mar 19
2/11
04:10 pm
alms
Form 5 ALUMIS INC. For: Dec 31 Filed by: Goldstein David M
Medium
Report
Form 5 ALUMIS INC. For: Dec 31 Filed by: Goldstein David M
1/28
07:22 pm
alms
Form 4 ALUMIS INC. For: Jan 26 Filed by: Pangali Sanam
Medium
Report
Form 4 ALUMIS INC. For: Jan 26 Filed by: Pangali Sanam
1/28
07:21 pm
alms
Form 4 ALUMIS INC. For: Jan 26 Filed by: Babler Martin
Medium
Report
Form 4 ALUMIS INC. For: Jan 26 Filed by: Babler Martin
1/28
07:20 pm
alms
Form 4 ALUMIS INC. For: Jan 26 Filed by: Hardiman Roy C.
Medium
Report
Form 4 ALUMIS INC. For: Jan 26 Filed by: Hardiman Roy C.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: